| FIEGL, M., M. ERDEL, I. TINHOFER, G. HOPFINGER, K. EIGENBERGER, F. FALKNER, A. FALKNER, Y. BRYCHTOVÁ, A. PANOVSKÁ, Michael DOUBEK, A. ZABERNIGG, S. SODIA, H. MÜHLBERGER, C. FONATSCH, G. GASTL, Jiří MAYER a R. GREIL. Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Follouwing Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories. Blood. 2008, roč. 112, č. 11, s. 1085-1085. |
Další formáty:
BibTeX
LaTeX
RIS
@article{822035,
author = {Fiegl, M. and Erdel, M. and Tinhofer, I. and Hopfinger, G. and Eigenberger, K. and Falkner, F. and Falkner, A. and Brychtová, Y. and Panovská, A. and Doubek, Michael and Zabernigg, A. and Sodia, S. and Mühlberger, H. and Fonatsch, C. and Gastl, G. and Mayer, Jiří and Greil, R.},
article_number = {11},
journal = {Blood},
title = {Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Follouwing Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories},
volume = {112},
year = {2008}
}
TY - JOUR
ID - 822035
AU - Fiegl, M. - Erdel, M. - Tinhofer, I. - Hopfinger, G. - Eigenberger, K. - Falkner, F. - Falkner, A. - Brychtová, Y. - Panovská, A. - Doubek, Michael - Zabernigg, A. - Sodia, S. - Mühlberger, H. - Fonatsch, C. - Gastl, G. - Mayer, Jiří - Greil, R.
PY - 2008
TI - Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Follouwing Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories
JF - Blood
VL - 112
IS - 11
SP - 1085-1085
EP - 1085-1085
ER -
FIEGL, M., M. ERDEL, I. TINHOFER, G. HOPFINGER, K. EIGENBERGER, F. FALKNER, A. FALKNER, Y. BRYCHTOVÁ, A. PANOVSKÁ, Michael DOUBEK, A. ZABERNIGG, S. SODIA, H. MÜHLBERGER, C. FONATSCH, G. GASTL, Jiří MAYER a R. GREIL. Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Follouwing Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories. \textit{Blood}. 2008, roč.~112, č.~11, s.~1085-1085.
|
